Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03866577
What this trial is testing

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Momenta Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07710248
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Hangzhou Sumgen Biotech Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00305435
What this trial is testing

Safety Study of AMG 531 in Japanese Subjects With ITP

Who this might be right for
Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Kyowa Kirin Co., Ltd. 12
Large-scale testing (Phase 3)Study completedNCT02868099
What this trial is testing

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Study completedNCT05757570
What this trial is testing

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
Alpine Immune Sciences Inc, A Subsidiary of Vertex 30
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Testing effectiveness (Phase 2)WithdrawnNCT00161564
What this trial is testing

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00117143
What this trial is testing

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Thrombocytopenic Purpura
Amgen 16